002907.SZ
华森制药
SZSE · Healthcare · C 制造业 · CN
CNY 14.31
+0.35%Year over year
Reported trailing growth
- Revenue
- +1.9%
- EBITDA
- —
- EBIT
- -13.8%
- EPS
- -25.0%
- Free cash flow
- -71.4%
- Operating cash flow
- -62.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.8%
- EBITDA
- +0.1%
- EBIT
- -4.8%
- Net income
- -12.9%
- EPS
- -13.9%
- Free cash flow
- -38.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026